Literature DB >> 26191355

Novel Pyrazine Amide Compounds.

Benjamin Blass1.   

Abstract

Entities:  

Year:  2015        PMID： 26191355      PMCID： PMC4499828          DOI： 10.1021/acsmedchemlett.5b00186

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Characteristics and pharmacological regulation of epithelial Na+ channel (ENaC) and epithelial Na+ transport.

Authors:  Yoshinori Marunaka
Journal:  J Pharmacol Sci       Date:  2014-08-23       Impact factor: 3.337

Review 2.  Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation.

Authors:  Matthias Schoenberger; Mike Althaus
Journal:  Expert Opin Ther Pat       Date:  2013-08-19       Impact factor: 6.674

3.  Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.

Authors:  Marcus A Mall
Journal:  Exp Physiol       Date:  2008-12-05       Impact factor: 2.969
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.